Pharmacokinetics of Procaterol in Elite Athletes

Bispebjerg Hospital

Status: Completed

Conditions: Asthma

Study type: Observational

Funder types: Other

Identifiers

NCT05749536

Procaterol

Details and patient eligibility

About

The purpose of the study is to find blood and urine concentrations of procaterol administrated either by inhalation or by tablets in asthmatic and non-asthmatics males. We hypotheis that the concentrations of procaterol in the blood and serum is higher after tablet intake versus inhalation.

Full description

Doping study

Enrollment: 20 patients

Sex: Male

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Doctor diagnosed asthma for the asthmatic group
• GINA 1-3 for the asthmatic group
• Use of beta2-agonist for at least 12 months for the asthmatic group
• age 18-45
• males
• informed consent

Exclusion criteria

• smoker or former smoker
• airway infection to weeks prior to the study or during the study
• other chronic diseaes than asthma and allergy
• Use of beta2-agonist 6 days prior to the study
• Allergy to the study medicine

Trial design

20 participants in 2 patient groups

Asthma

Description:

With positive asthma test

Healthy

Description:

With no signs of asthma